Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024
Singular Genomics Systems (Nasdaq: OMIC), a company specializing in next-generation sequencing (NGS) and spatial multiomics technologies, has announced its plans to report second quarter 2024 financial results on August 13, 2024, after market close. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results.
Investors can join the call by dialing 1-888-506-0062 (domestic) or 1-973-528-0011 (international) using conference ID 661035. A live and archived webcast will be available on the company's investor relations website.
Singular Genomics Systems (Nasdaq: OMIC), un'azienda specializzata in tecnologie di sequenziamento di nuova generazione (NGS) e multiomics spaziali, ha annunciato i suoi piani per riportare i risultati finanziari del secondo trimestre 2024 il 13 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una chiamata in conferenza alle 13:30 ora del Pacifico / 16:30 ora dell'Est per discutere i risultati.
Gli investitori possono partecipare alla chiamata componendo 1-888-506-0062 (nazionale) o 1-973-528-0011 (internazionale) utilizzando l'ID conferenza 661035. Un webcast dal vivo e archiviato sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda.
Singular Genomics Systems (Nasdaq: OMIC), una empresa especializada en tecnologías de secuenciación de nueva generación (NGS) y multiómicas espaciales, ha anunciado sus planes para informar sobre los resultados financieros del segundo trimestre de 2024 el 13 de agosto de 2024, después del cierre del mercado. La empresa llevará a cabo una llamada de conferencia a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este para discutir los resultados.
Los inversores pueden unirse a la llamada marcando 1-888-506-0062 (nacional) o 1-973-528-0011 (internacional) utilizando el ID de conferencia 661035. Se disponibilizará un webcast en vivo y grabado en el sitio web de relaciones con inversores de la empresa.
싱귤러 게노믹스 시스템즈(Singular Genomics Systems, 나스닥: OMIC)는 차세대 염기서열 분석(NGS) 및 공간 다중 오믹스 기술을 전문으로 하는 회사로, 2024년 2분기 재무 결과를 2024년 8월 13일 시장 마감 후 발표할 계획이라고 발표했습니다. 회사는 결과를 논의하기 위해 태평양 표준시 오후 1시 30분 / 동부 표준시 오후 4시 30분에 컨퍼런스 콜을 진행할 예정입니다.
투자자는 1-888-506-0062 (국내) 또는 1-973-528-0011 (국제)를 전화하여 661035 콘퍼런스 ID를 사용하여 전화를 걸 수 있습니다. 회사의 투자자 관계 웹사이트에서 생중계와 보관된 웹캐스트를 이용할 수 있습니다.
Singular Genomics Systems (Nasdaq : OMIC), une entreprise spécialisée dans les technologies de séquençage de nouvelle génération (NGS) et de multiomiques spatiales, a annoncé son intention de publier ses résultats financiers du deuxième trimestre 2024 le 13 août 2024, après la fermeture des marchés. L'entreprise organisera une conférence téléphonique à 13h30, heure du Pacifique / 16h30, heure de l'Est pour discuter des résultats.
Les investisseurs peuvent participer à l'appel en composant 1-888-506-0062 (national) ou 1-973-528-0011 (international) en utilisant l'ID de conférence 661035. Un webinaire en direct et archivé sera disponible sur le site des relations avec les investisseurs de l'entreprise.
Singular Genomics Systems (Nasdaq: OMIC), ein auf Nächste-Generation-Sequenzierung (NGS) und räumliche Multiomics-Technologien spezialisiertes Unternehmen, hat angekündigt, seine Finanzberichte für das zweite Quartal 2024 am 13. August 2024 nach Börsenschluss zu veröffentlichen. Das Unternehmen wird um 13:30 Uhr pazifischer Zeit / 16:30 Uhr östlicher Zeit eine Telefonkonferenz abhalten, um die Ergebnisse zu diskutieren.
Investoren können an der Konferenz teilnehmen, indem sie 1-888-506-0062 (national) oder 1-973-528-0011 (international) wählen und die Konferenz-ID 661035 verwenden. Eine Live- und archivierte Webcast wird auf der Investor-Relations-Website des Unternehmens bereitgestellt.
- None.
- None.
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the second quarter ended June 30, 2024 after the market close on Tuesday, August 13, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by dialing 1-888-506-0062 for domestic callers or 1-973-528-0011 for international callers and using conference ID 661035 approximately five minutes prior to the start time. A live and archived webcast of the event will be available at investor.singulargenomics.com in the Presentations & Events section.
About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4® Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In addition, the company is currently developing the G4X™ Spatial Sequencer, which will leverage Singular’s proprietary sequencing technology, applying it as an in situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.
Investor Contact
Philip Taylor
ir@singulargenomics.com
Media Contact
Matt Browning
pr@singulargenomics.com
FAQ
When will Singular Genomics (OMIC) report its Q2 2024 financial results?
What time is Singular Genomics' (OMIC) Q2 2024 earnings call scheduled for?
How can investors listen to Singular Genomics' (OMIC) Q2 2024 earnings call?
Where can I find the webcast for Singular Genomics' (OMIC) Q2 2024 earnings call?
